A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases

SIMPLE SUMMARY: Many cancer patients with bone metastases receive palliative radiotherapy. The patients’ remaining lifespan should be considered to achieve optimal treatment personalization. Since elderly patients (≥65 years) are different from younger ones, a specific survival score was developed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rades, Dirk, Delikanli, Cansu, Schild, Steven E., Kristiansen, Charlotte, Tvilsted, Søren, Janssen, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563043/
https://www.ncbi.nlm.nih.gov/pubmed/36230602
http://dx.doi.org/10.3390/cancers14194679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563043/
https://www.ncbi.nlm.nih.gov/pubmed/36230602
http://dx.doi.org/10.3390/cancers14194679

Ejemplares similares